[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632202":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":28,"responsibleParty":47,"collaborators":49,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":11,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":31,"whyStopped":11,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Vision Innovation Centers of Pennsylvania, LLC d\u002Fb\u002Fa Eye Care Specialists","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Lacrifill","EXPERIMENTAL",null,[13],"Drug: Lacrifill",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"DRUG","Lacrifill is a cross-linked hyaluronic acid derivative that temporarily blocks tear drainage, allowing patients eyed to be bathed in their own natural tears.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Patti Myers, COT","CONTACT","5707145910","patti.myers@vipeyes.com",{"name":26,"role":22,"phone":27,"phoneExt":11,"email":11},"Cheryl Bayley","5707145915",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Eye Care Specialists","RECRUITING","Kingston","Pennsylvania","18704","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-75.89686,41.26175,{"lat":41,"lon":40},[44],{"name":45,"role":22,"phone":46,"phoneExt":11,"email":24},"Patti Myers","877-489-7405",{"type":48,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[50],{"name":51,"class":52},"Nordic Pharma, USA","INDUSTRY","100632202","phase-4-single-arm-study-of-a-treatment-for-dry-eye-in-people-who-struggle-to-wear-contact-lenses-100632202",false,"NCT07510620","Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses","Prospective, Single Arm Clinical Trial for the Treatment of Dry Eyes Signs and Symptoms in Patients With Limited Tolerability of Contact Lens Wear","Inclusion Criteria\n\n* \\>21 years of age\n* Contact lens wearer\n* Previous Dry Eye Treatment\n* Be on a stable dose of antihistamines\u002FBirth Control Medication and Lifitegrast and cyclosporine.\n* Schrimers Anesthetized less than or equal to 10\n* CLDEQ-8 greater than or equal to 12\n* Corneal Staining NEI grading scale greater than or equal to 1\n\nExclusion Criteria:\n\n* Known allergy to Hyaluronic Acid\n* Current topical ophthalmic drops other than dry eye treatment\n* Uncontrolled Diabetes\n* Diabetic Retinopathy\n* Pregnancy or Lactating\n* Corneal Surgery (except Refractive)\n* Corneal Scars\n* Keratoconus\n* Ocular Herpetic Keratitis","ALL","22 Years",{"count":63,"type":64},30,"ESTIMATED","INTERVENTIONAL",[67],"PHASE4","This research study is to see if using Lacrifill is safe, easy to use, and helpful for people who wear contact lenses but can't wear them comfortably for long. Specifically, the study aims to determine whether regular use of Lacrifill over a 2-3 month period can help people wear their contacts longer without discomfort and reduce signs and symptoms of dry eye.",[70],"Dry Eye",[70,9,72],"contact lenses","2026-04-01",{"date":75,"type":76},"2026-04-03","ACTUAL",{"date":78,"type":76},"2025-12-12",{"date":80,"type":64},"2026-08",{"name":5,"class":6},1]